CLEVER: Claudication treatment—comparative effectiveness of treatment approaches for PAD
Loading...
Loading...
230
views
Loading...
46 videosScientific Sessions 2011- 8:31
ADOPT: Apixaban vs. enoxaparin dosing to treat VTEby AHAScienceNews252 views
- 3:11
PALLAS: dronedarone in addition to standard therapy for patients with heart failureby AHAScienceNews125 views
- 2:53
Cardiovascular Nursing Clinical Symposiumby AHAScienceNews106 views
- 1:22
Alan's calf pain (claudication) cureby dryoo2205 views
- 6:06
EASE: Early surgery versus conventional treatment for infective endocarditisby AHAScienceNews325 views
- 6:53
ELEVATE-TIMI 56: a genetic strategy for clopidogrel dosingby AHAScienceNews369 views
- 5:38
Monday LBCT3 Recap: New antiarrhythmic drugs and arrhythmia strategiesby AHAScienceNews180 views
- 8:12
AIM-HIGH: Extended-release niacin does not reduce clinical eventsby AHAScienceNews459 views
- 12:04
Tuesday LBCT4 Recap: Prevention--POWER, SATURN, AIM-High and moreby AHAScienceNews197 views
- 6:23
FAST: Ablation of AF -- catheter or surgery?by AHAScienceNews350 views
- 9:03
Wednesday LBCT5 Recap: EASE, ELEVATE-TIMI 56, and moreby AHAScienceNews79 views
- 3:20
Preview: Late-Breaking Clinical Trials Iby AHAScienceNews285 views
- 4:30
Preview: Late-Breaking Clinical Trials Vby AHAScienceNews69 views
- 8:28
Peripheral Artery Disease presented by Moorpark College Student Nursesby carolvelas143931 views
- 3:32
Preview: Late-Breaking Clinical Trials IIIby AHAScienceNews100 views
- 2:09
Exercises for Better Health : How Do I Exercise for Spinal Stenosis?by ehowhealth1,139 views
- 9:21
Sessions Program Chair Elliott Antman Highlights the Results of LBCT Vby AHAScienceNews75 views
- 6:27
SCIPIO: Cardiac stem cells and postinfarction heart failureby AHAScienceNews1,218 views
- 7:05
TRA•CER: Novel PAR-1 inhibitor, vorapaxar, in ACS patientsby AHAScienceNews323 views
- 5:39
ISAR-REACT 4: Abciximab plus Heparin versus Bivalirudin in patients with non-STEMI undergoing PCIby AHAScienceNews179 views
Link to this comment:
All Comments (0)